Collaborative Research Centre 1755: Cellular and Systems Control of AutoImmune Disease
CASCAID – Cellular and Systemic Control of Autoimmune Disease
Chronic autoimmune diseases such as rheumatoid arthritis, lupus, and inflammatory bowel disease often occur in recurring flare-ups and can lead to progressive organ damage. At Universitätsklinikum Erlangen, the newly established Collaborative Research Center CRC 1755 CASCAID, funded by the Deutsche Forschungsgemeinschaft, investigates the immune networks and tissue mechanisms that drive these chronic inflammatory conditions.
The goal of CASCAID is to better understand why autoimmune diseases can remain symptom-free for certain periods and why relapses still occur. By combining clinical research, advanced tissue profiling, and innovative therapeutic approaches, the programme explores how the immune system can be reset to achieve sustained remission without the need for continuous medication.
Innovative Therapies for Long-Term Disease Control
CAR-T cell Therapy
Regulatory T cells (Tregs)
T-cell engagers
These approaches aim to transform the treatment of autoimmune diseases by enabling long-term disease control and providing lasting relief from chronic inflammation. By integrating basic science with clinical research, CASCAID creates a strong translational research environment.
Large patient cohorts, tissue analyses, and clinical studies provide essential data to accelerate the transfer of scientific discoveries into real-world clinical applications.
Study identifies new prospects for women with autoimmune diseases
Autoimmune diseases such as systemic lupus erythematosus mainly affect young women, often in a phase of their lives where they would like to have children. The diseases themselves or the immunosuppressive drugs required to treat …
Every breakthrough in medicine only changes lives when people understand it.
That’s why we create digital experiences that transform complex immunology into knowledge, confidence, and hope.
#BackToHealth is more than just a hashtag: It is the vision that unites everything we create.
At this…
A new Collaborative Research Center investigates the mechanisms of autoimmune diseases and innovative cell-based therapies
Autoimmune diseases often follow a relapsing course: periods without signs of disease are interrupted by flare-ups, despite significant advances in treatment. Why these rel…